首页> Bone marrow transplantation> Low-dose decitabine as part of a modified Bu-Cy conditioning regimen improves survival in AML patients with active disease undergoing allogeneic hematopoietic stem cell transplantation.

Low-dose decitabine as part of a modified Bu-Cy conditioning regimen improves survival in AML patients with active disease undergoing allogeneic hematopoietic stem cell transplantation.

导出 LinkOut

翻译打印收藏纠错

第一作者： Xiaowen,Tang

第一单位： National Clinical Research Center for Hematologic Diseases, The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, Suzhou, China. xwtang1020@163.com.;Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China. xwtang1020@163.com.

作者： Xiaowen,Tang ^[1] ; Benigno C,Valdez ^[2] ; Yunju,Ma ^[3] ; Qianqian,Zhang ^[3] ; Changju,Qu ^[3] ; Haiping,Dai ^[3] ; Jia,Yin ^[3] ; Zheng,Li ^[3] ; Ting,Xu ^[3] ; Yang,Xu ^[3] ; Jia,Chen ^[3] ; Xiaming,Zhu ^[3] ; Zixing,Chen ^[3] ; Depei,Wu ^[4] ; Borje S,Andersson ^[2]

作者单位： National Clinical Research Center for Hematologic Diseases, The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, Suzhou, China. xwtang1020@163.com.;Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China. xwtang1020@163.com. ^[1] Department of Stem Cell Transplantation & Cellular Therapy, UT MD Anderson Cancer Center, Houston, TX, USA. ^[2] National Clinical Research Center for Hematologic Diseases, The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, Suzhou, China.;Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China. ^[3] National Clinical Research Center for Hematologic Diseases, The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, Suzhou, China. drwudepei@163.com.;Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China. drwudepei@163.com. ^[4]